Actinium Presents Positive Findings from Mid-Point Analysis of Pivotal SIERRA Trial of Iomab-B at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT)
Stock Information for Actinium Pharmaceuticals Inc. (Delaware)
Loading
Please wait while we load your information from QuoteMedia.